Takeda Pharmaceutical (TAK) net assets (shareholders' equity)

Net assets · fiscal 2026
¥7.43T

Takeda Pharmaceutical (TAK) had net assets of ¥7.43T at the end of fiscal 2026 (March 31, 2026). That is 7.1% higher than the ¥6.94T of fiscal 2025. Figures as of 19 Nov 2026, 20:11 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2026
¥7.43T
Change on fiscal 2025
+7.1%
Highest on record
¥7.43Tfiscal 2026
Lowest on record
¥6.35Tfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥7.43T in fiscal 2026 and the lowest ¥6.35T in fiscal 2023.

History · 4 fiscal years

Net assets by fiscal year

Takeda Pharmaceutical net assets (shareholders' equity), year by year

Takeda Pharmaceutical (TAK) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2026¥7.43T 7.1% up
2025¥6.94T 4.6% down
2024¥7.27T 14.5% up
2023¥6.35T—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Takeda Pharmaceutical and comparable companies
CompanyNet assetsFiscal year
Takeda Pharmaceutical TAK¥7.43T2026
Cencora COR$1.51B2025
Boston Scientific BSX$24.23B2025
Cardinal Health CAH-$2.88B2026
argenx ARGX$7.32B2025
Edwards Lifesciences EW$10.34B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical net assets (shareholders' equity): questions and answers

What are Takeda Pharmaceutical's net assets?

Takeda Pharmaceutical (TAK) had net assets of ¥7.43T at the end of fiscal 2026 (March 31, 2026). That is 7.1% higher than the ¥6.94T of fiscal 2025.

What are the highest and lowest net assets figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥7.43T in fiscal 2026 and the lowest ¥6.35T in fiscal 2023.

How is Takeda Pharmaceutical's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Takeda Pharmaceutical it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/TAK/net-assets

Underlying data: Yahoo Finance.